Brief: Inovio Reports Fourth Quarter Results
06/03/2024 21:09
March 6 (Reuters) - Inovio Pharmaceuticals Inc INO.O :
* INOVIO REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* INOVIO PHARMACEUTICALS INC: PROJECTS CASH RUNWAY INTO Q2
2025
* INOVIO PHARMACEUTICALS INC - NET LOSS FOR QUARTER WAS
$25.0
MILLION, OR $1.10 PER BASIC AND DILUTED SHARE
Source text for Eikon: ID:nPn2PlYc6a
Further company coverage: INO.O
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million